Lifeworks Advisors LLC increased its stake in Regeneron Pharmaceuticals by 31.5%, now holding 6,743 shares worth $4.8 million ...

Dorsey & Whitney Trust cut its Lockheed Martin stake by 28.8% in Q4, selling 643 shares worth $771,000. Other institutional ...

Cigna’s CFO, Brian Evanko, addressed financial and operational updates at the Barclays Healthcare Conference. The company ...

Bristol-Myers Squibb (BMY) is ranked 5th among the best pharma stocks to buy according to hedge funds. The company boasts a ...

Boston Scientific closed at $95.52, rising 1.48% while the broader market declined. The S&P 500 fell 0.76%, the Dow dropped 1 ...

Marsh & McLennan’s CEO, Dean Michael Klisura, sold 7,121 shares worth $1.67 million, reducing his ownership by 25.38%. The ...

Christopher D’Ambrosio, a VP at ADP, sold 473 shares for $144,832 under a pre-established trading plan. He also exercised ...

Personal CFO Solutions LLC slashed its stake in CVS Health by 62.5%, reducing its holdings to $450,000. Several other hedge ...

KLA Corp. is gaining traction as a top Growth at a Reasonable Price (GARP) stock. The company posted a strong 23.7% revenue ...

Banco Santander S.A. cut its stake in Mondelez International by 85.3% in Q4, selling 88,784 shares. The institutional ...

Alibaba’s stock dipped 1.9% to $136.40, with trading volume significantly lower than usual. Despite this, analysts remain ...

Southwest Airlines is ending its long-standing free baggage policy, giving rivals a chance to lure away price-sensitive ...